Lv7
3440 积分 2024-12-24 加入
Novel pharmacological approaches to lowering blood pressure and managing hypertension
2天前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
2天前
已完结
Efficacy and Safety of Pharmacological Interventions in Managing Cardiometabolic Risk Factors in Youth Living with Overweight and Obesity: A Systematic Review and Network Meta‐Analysis
5个月前
已完结
A machine learning model using echocardiographic myocardial strain to detect myocardial ischemia
5个月前
已关闭
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical data
6个月前
已完结
Glucagon and energy expenditure; Revisiting amino acid metabolism and implications for weight loss therapy
6个月前
已完结
Deliberating the striking effect of dual GLP-1R and GIPR agonists on “Diabesity” in light of precision medicine and pharmacogenomics
6个月前
已完结
Next Generation Dual GLP-1/GIP, GLP-1/Glucagon, and Triple GLP-1/GIP/Glucagon Agonists: A Literature Review
6个月前
已完结
Transforming obesity: The advancement of multi-receptor drugs
6个月前
已完结
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
6个月前
已完结
皖公网安备34019202002308
